Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
出版年份 2016 全文链接
标题
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
作者
关键词
-
出版物
Genes
Volume 7, Issue 9, Pages 56
出版商
MDPI AG
发表日期
2016-09-01
DOI
10.3390/genes7090056
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hippocampal metabotropic glutamate receptor long-term depression in health and disease: focus on mitogen-activated protein kinase pathways
- (2016) Thomas M. Sanderson et al. JOURNAL OF NEUROCHEMISTRY
- Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS
- (2015) Sally M. Till et al. HUMAN MOLECULAR GENETICS
- Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release
- (2015) S.-H. Lee et al. JOURNAL OF NEUROSCIENCE
- Minireview: From the Bench, Toward the Clinic: Therapeutic Opportunities for Cannabinoid Receptor Modulation
- (2015) Robert P. Picone et al. MOLECULAR ENDOCRINOLOGY
- Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner
- (2015) Ferenc Zádor et al. NEUROPHARMACOLOGY
- Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
- (2015) Lara Costa et al. Frontiers in Behavioral Neuroscience
- New insights into the molecular pathophysiology of fragile X syndrome and therapeutic perspectives from the animal model
- (2014) Arnau Busquets-Garcia et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Genetic Removal of Matrix Metalloproteinase 9 Rescues the Symptoms of Fragile X Syndrome in a Mouse Model
- (2014) H. Sidhu et al. JOURNAL OF NEUROSCIENCE
- Targeting the endocannabinoid system in the treatment of fragile X syndrome
- (2013) Arnau Busquets-Garcia et al. NATURE MEDICINE
- Lovastatin Corrects Excess Protein Synthesis and Prevents Epileptogenesis in a Mouse Model of Fragile X Syndrome
- (2013) Emily K. Osterweil et al. NEURON
- Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
- (2012) Cristoforo Silvestri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity
- (2012) F J Meye et al. MOLECULAR PSYCHIATRY
- Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice
- (2012) Aditi Bhattacharya et al. NEURON
- Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
- (2012) Aubin Michalon et al. NEURON
- Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen
- (2012) C. Henderson et al. Science Translational Medicine
- Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome
- (2012) Kwang-Mook Jung et al. Nature Communications
- Defective GABAergic Neurotransmission and Pharmacological Rescue of Neuronal Hyperexcitability in the Amygdala in a Mouse Model of Fragile X Syndrome
- (2010) J. L. Olmos-Serrano et al. JOURNAL OF NEUROSCIENCE
- Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome
- (2010) L. Zhang et al. JOURNAL OF NEUROSCIENCE
- Mechanism-based approaches to treating fragile X
- (2010) Gül Dölen et al. PHARMACOLOGY & THERAPEUTICS
- Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome
- (2010) A. Suvrathan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fragile X syndrome: from molecular genetics to therapy
- (2009) C D'Hulst et al. JOURNAL OF MEDICAL GENETICS
- Central and peripheral consequences of the chronic blockade of CB1cannabinoid receptor with rimonabant or taranabant
- (2009) Elena Martín-García et al. JOURNAL OF NEUROCHEMISTRY
- Endocannabinoid-Mediated Control of Synaptic Transmission
- (2009) Masanobu Kano et al. PHYSIOLOGICAL REVIEWS
- Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
- (2007) Diego Centonze et al. BIOLOGICAL PSYCHIATRY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started